Proteomic analysis of uropathogenic Escherichia coli

References

• Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004;2(2):123-40
   PubMed Web of Science ®Google Scholar
• Clements A, Young JC, Constantinou N, Frankel G. Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes 2012;3(2):71-87
   PubMed Web of Science ®Google Scholar
• Marrs CF, Zhang L, Foxman B. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett 2005;252(2):183-90
   PubMedGoogle Scholar
• Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun 2005;73(1):18-29
   PubMedGoogle Scholar
• Miquel S, Peyretaillade E, Claret L, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS ONE 2010;5:9
   PubMedGoogle Scholar
• Nash JH, Villegas A, Kropinski AM, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics 2010;11:667
   PubMed Web of Science ®Google Scholar
• Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007;4(2):134-63
   PubMed Web of Science ®Google Scholar
• Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: “the other bad E coli”. J Lab Clin Med 2002;139(3):155-62
   PubMed Web of Science ®Google Scholar
• Xie Y, Kolisnychenko V, Paul-Satyaseela M, et al. Identification and characterization of Escherichia coli RS218-derived islands in the pathogenesis of E. coli meningitis. J Infect Dis 2006;194(3):358-64
   PubMedGoogle Scholar
• Zhu L, Pearce D, Kim KS. Prevention of Escherichia coli K1 penetration of the blood-brain barrier by counteracting the host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells. Infect Immun 2010;78(8):3554-9
   PubMedGoogle Scholar
• Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(Suppl 1A):5S-13S
   PubMed Web of Science ®Google Scholar
• Imirzalioglu C, Hain T, Chakraborty T, Domann E. Hidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia 2008;40(2):66-71
   PubMed Web of Science ®Google Scholar
• Moreno E, Andreu A, Perez T, et al. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006;134(5):1015-23
   PubMedGoogle Scholar
• Barber AE, Norton JP, Spivak AM, Mulvey MA. Urinary tract infections: current and emerging management strategies. Clin Infect Dis 2013;57(5):719-24
   PubMedGoogle Scholar
• Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003;301(5629):105-7
   PubMed Web of Science ®Google Scholar
• Justice SS, Hung C, Theriot JA, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004;101(5):1333-8
   PubMed Web of Science ®Google Scholar
• Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010;54(5):1855-63
   PubMed Web of Science ®Google Scholar
• Hunstad DA, Justice SS. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 2010;64:203-21
   PubMed Web of Science ®Google Scholar
• Czaja CA, Stamm WE, Stapleton AE, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 2009;200(4):528-36
   PubMedGoogle Scholar
• Chen SL, Wu M, Henderson JP, et al. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med 2013;5(184):184ra60
   PubMed Web of Science ®Google Scholar
• Norinder BS, Koves B, Yadav M, et al. Do Escherichia coli strains causing acute cystitis have a distinct virulence repertoire? Microb Pathog 2012;52(1):10-16
   PubMedGoogle Scholar
• Mobley HL, Green DM, Trifillis AL, et al. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 1990;58(5):1281-9
   PubMed Web of Science ®Google Scholar
• Welch RA, Burland V, Plunkett G III, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002;99(26):17020-4
   PubMed Web of Science ®Google Scholar
• Brzuszkiewicz E, Bruggemann H, Liesegang H, et al. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 2006;103(34):12879-84
   PubMed Web of Science ®Google Scholar
• Schneider G, Dobrindt U, Middendorf B, et al. Mobilisation and remobilisation of a large archetypal pathogenicity island of uropathogenic Escherichia coli in vitro support the important role of conjugation for horizontal transfer of genomic islands. BMC Microbiol 2011;11(1):210
   PubMedGoogle Scholar
• Subashchandrabose S, Hazen TH, Rasko DA, Mobley HL. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates. Pathog Dis 2013; [Epub ahead of print]
   PubMedGoogle Scholar
• Sabate M, Moreno E, Perez T, et al. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 2006;12(9):880-6
   PubMed Web of Science ®Google Scholar
• Bingen-Bidois M, Clermont O, Bonacorsi S, et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 2002;70(6):3216-26
   PubMedGoogle Scholar
• Avasthi TS, Kumar N, Baddam R, et al. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol 2011;193(16):4272-3
   PubMedGoogle Scholar
• Chen SL, Hung CS, Xu J, et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc Natl Acad Sci USA 2006;103(15):5977-82
   PubMed Web of Science ®Google Scholar
• Vejborg RM, Hancock V, Schembri MA, Klemm P. Comparative genomics of Escherichia coli strains causing urinary tract infections. Appl Environ Microbiol 2011;77(10):3268-78
   PubMedGoogle Scholar
• Zhang L, Foxman B. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 2003;8:e235-44
   Google Scholar
• Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol 2002;12(1):33-8
   PubMedGoogle Scholar
• Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 2008;85(1):11-19
   PubMed Web of Science ®Google Scholar
• Mao BH, Chang YF, Scaria J, et al. Identification of Escherichia coli genes associated with urinary tract infections. J Clin Microbiol 2012;50(2):449-56
   PubMedGoogle Scholar
• Vejborg RM, de Evgrafov MR, Phan MD, et al. Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine. Infect Immun 2012;80(9):3179-88
   PubMedGoogle Scholar
• Touchon M, Hoede C, Tenaillon O, et al. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 2009;5(1):e1000344
   PubMed Web of Science ®Google Scholar
• Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012;2012:681473
   PubMedGoogle Scholar
• Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002;4(5):257-71
   PubMedGoogle Scholar
• Antao EM, Wieler LH, Ewers C. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog 2009;1(1):22
   PubMedGoogle Scholar
• Leffler H, Eden CS. Chemical identification of a glycospingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 2013;8:127-34
   Google Scholar
• Mokady D, Gophna U, Ron EZ. Virulence factors of septicemic Escherichia coli strains. Int J Med Microbiol 2005;295(6-7):455-62
   PubMedGoogle Scholar
• Mokady D, Gophna U, Ron EZ. Extensive gene diversity in septicemic Escherichia coli strains. J Clin Microbiol 2005;43(1):66-73
   PubMed Web of Science ®Google Scholar
• Moulin-Schouleur M, Schouler C, Tailliez P, et al. Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. J Clin Microbiol 2006;44(10):3484-92
   PubMed Web of Science ®Google Scholar
• Snyder JA, Haugen BJ, Buckles EL, et al. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 2004;72(11):6373-81
   PubMed Web of Science ®Google Scholar
• Martinez JJ, Mulvey MA, Schilling JD, et al. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 2000;19(12):2803-12
   PubMed Web of Science ®Google Scholar
• Connell H, Agace WW, Klemms P, et al. Svanborg, C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 1996;93:9827-32
   PubMed Web of Science ®Google Scholar
• Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol 2007;9(9):2230-41
   PubMed Web of Science ®Google Scholar
• Hadjifrangiskou M, Hultgren SJ. What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli. Virulence 2012;3(3):231-3
   PubMed Web of Science ®Google Scholar
• Hagan EC, Lloyd AL, Rasko DA, et al. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010;6(11):e1001187
   PubMed Web of Science ®Google Scholar
• Schmidt H, Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev 2004;17(1):14-56
   PubMed Web of Science ®Google Scholar
• Sunden F, Hakansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol 2010;184(1):179-85
   PubMedGoogle Scholar
• Zdziarski J, Svanborg C, Wullt B, et al. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 2008;76(2):695-703
   PubMedGoogle Scholar
• Mabbett AN, Ulett GC, Watts RE, et al. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 2009;299(1):53-63
   PubMedGoogle Scholar
• Salvador E, Wagenlehner F, Kohler CD, et al. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012;80(2):668-78
   PubMedGoogle Scholar
• Dobrindt U, Agerer F, Michaelis K, et al. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 2003;185(6):1831-40
   PubMed Web of Science ®Google Scholar
• Hancock V, Seshasayee AS, Ussery DW, et al. Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972. Mol Genet Genomics 2008;279(5):523-34
   PubMedGoogle Scholar
• Vejborg RM, Friis C, Hancock V, et al. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073. Nissle 1917 and ABU 83972. Mol Genet Genomics 2010;283(5):469-84
   PubMed Web of Science ®Google Scholar
• Grozdanov L, Raasch C, Schulze J, et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 2004;186(16):5432-41
   PubMed Web of Science ®Google Scholar
• Sun J, Gunzer F, Westendorf AM, et al. Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 2005;117(2):147-61
   PubMed Web of Science ®Google Scholar
• Hancock V, Vejborg RM, Klemm P. Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation. Mol Genet Genomics 2010;284(6):437-54
   PubMed Web of Science ®Google Scholar
• Roos V, Nielsen EM, Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 2006;262(1):22-30
   PubMedGoogle Scholar
• Roos V, Klemm P. Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 2006;74(6):3565-75
   PubMed Web of Science ®Google Scholar
• Russo TA, Jodush ST, Brown JJ, Johnson JR. Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol 1996;22(2):217-29
   PubMedGoogle Scholar
• O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21
   PubMed Web of Science ®Google Scholar
• Neidhardt FC, Vaughn V, Phillips TA, Bloch PL. Gene-protein index of Escherichia coli K-12. Microbiol Rev 1983;47(2):231-84
   PubMedGoogle Scholar
• VanBogelen RA, Abshire KZ, Pertsemlidis A, et al. Gene-protein database of Escherichia coli K-12, Edition 6. In: Neidhardt FC, Curtiss R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE, editors. Escherichia coli and salmonella: cellular and molecular biology. 2nd edition. ASM Press; Washington, DC, USA: 1996. p. 2067-117
   Google Scholar
• VanBogelen RA, Abshire KZ, Moldover B, et al. Escherichia coli proteome analysis using the gene-protein database. Electrophoresis 1997;18:1243-51
   PubMed Web of Science ®Google Scholar
• Franzel B, Wolters DA. Advanced MudPIT as a next step toward high proteome coverage. Proteomics 2011;11(18):3651-6
   PubMedGoogle Scholar
• Mosteller RD, Goldstein RV, Nishimoto KR. Metabolism of individual proteins in exponentially growing Escherichia coli. J Biol Chem 1980;255:2524-32
   PubMedGoogle Scholar
• Blom A, Harder W, Matin A. Unique and overlapping pollutant stress proteins of Escherichia coli. Appl Environ Microbiol 1992;58:331-4
   PubMed Web of Science ®Google Scholar
• Perrot F, Hebraud M, Junter GA, Jouenne T. Protein synthesis in Escherichia coli at 4 degrees C. Electrophoresis 2000;21(8):1625-9
   PubMedGoogle Scholar
• Yohannes E, Barnhart DM, Slonczewski JL. pH-dependent catabolic protein expression during anaerobic growth of Escherichia coli K-12. J Bacteriol 2004;186(1):192-9
   PubMedGoogle Scholar
• Lippolis JD, Bayles DO, Reinhardt TA. Proteomic changes in Escherichia coli when grown in fresh milk versus laboratory media. J Proteome Res 2009;8(1):149-58
   PubMed Web of Science ®Google Scholar
• Papanastasiou M, Orfanoudaki G, Koukaki M, et al. The Escherichia coli peripheral inner membrane proteome. Mol Cell Proteomics 2013;12(3):599-610
   PubMedGoogle Scholar
• Smith A, van Rooyen JP, Argo E, Cash P. Proteomic analysis of Escherichia coli associated with urinary tract infections. Proteomics 2011;11(11):2283-93
   PubMedGoogle Scholar
• Zdziarski J, Brzuszkiewicz E, Wullt B, et al. Host imprints on bacterial genomes – rapid, divergent evolution in individual patients. PLoS Pathog 2010;6(8):e1001078
   Google Scholar
• Alteri CJ, Mobley HL. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect Immun 2007;75(6):2679-88
   PubMedGoogle Scholar
• Alteri CJ, Smith SN, Mobley HL. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 2009;5(5):e1000448
   PubMed Web of Science ®Google Scholar
• Korea CG, Ghigo JM, Beloin C. The sweet connection: solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: multiple E. coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonisation and tissue tropism. Bioessays 2011;33(4):300-11
   PubMedGoogle Scholar
• Ulett GC, Totsika M, Schaale K, et al. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 2013;16(1):100-7
   PubMedGoogle Scholar
• Allsopp LP, Totsika M, Tree JJ, et al. UpaH is a newly identified autotransporter protein that contributes to biofilm formation and bladder colonization by uropathogenic Escherichia coli CFT073. Infect Immun 2010;78(4):1659-69
   PubMedGoogle Scholar
• Allsopp LP, Beloin C, Ulett GC, et al. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 2012;80(1):321-32
   PubMedGoogle Scholar
• Lane MC, Alteri CJ, Smith SN, Mobley HL. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci USA 2007;104(42):16669-74
   PubMed Web of Science ®Google Scholar
• Hagan EC, Mobley HL. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect Immun 2007;75(8):3941-9
   PubMed Web of Science ®Google Scholar
• Walters MS, Mobley HL. Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. J Microbiol Methods 2009;78(2):131-5
   PubMedGoogle Scholar
• Hull RA, Hull SI. Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 1997;65(5):1960-1
   PubMed Web of Science ®Google Scholar
• Aubron C, Huet O, Ricome S, et al. Changes in urine composition after trauma facilitate bacterial growth. BMC Infect Dis 2012;12:330
   PubMedGoogle Scholar
• Hsiao A, Zhu J. Genetic tools to study gene expression during bacterial pathogen infection. Adv Appl Microbiol 2009;67:297-314
   PubMedGoogle Scholar
• Rabilloud T, Chevallet M, Luche S, Lelong C. Fully denaturing two-dimensional electrophoresis of membrane proteins: a critical update. Proteomics 2008;8(19):3965-73
   PubMedGoogle Scholar
• Alteri CJ, Mobley HL. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 2012;15(1):3-9
   PubMedGoogle Scholar
• Moxon R, Tang C. Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens. Philos Trans R Soc Lond B Biol Sci 2000;355(1397):643-56
   PubMed Web of Science ®Google Scholar
• Henderson JP, Crowley JR, Pinkner JS, et al. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 2009;5(2):e1000305
   PubMed Web of Science ®Google Scholar
• Reigstad CS, Hultgren SJ, Gordon JI. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem 2007;282(29):21259-67
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Totsika M, Mansfield KJ, et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev 2012;36(3):616-48
   PubMed Web of Science ®Google Scholar
• Cash P. Proteomics of bacterial pathogens. Expert Opin Drug Discov 2008;3(5):461-73
   PubMed Web of Science ®Google Scholar
• Gibreel TM, Dodgson AR, Cheesbrough J, et al. High metabolic potential may contribute to the success of ST131 uropathogenic Escherichia coli. J Clin Microbiol 2012;50(10):3202-7
   PubMedGoogle Scholar
• Bleibtreu A, Gros PA, Laouenan C, et al. Fitness, stress resistance, and extraintestinal virulence in Escherichia coli. Infect Immun 2013;81(8):2733-42
   PubMedGoogle Scholar
• Roesch PL, Redford P, Batchelet S, et al. Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol Microbiol 2003;49(1):55-67
   PubMedGoogle Scholar
• Anfora AT, Welch RA. DsdX is the second D-serine transporter in uropathogenic Escherichia coli clinical isolate CFT073. J Bacteriol 2006;188(18):6622-8
   PubMedGoogle Scholar
• Anfora AT, Haugen BJ, Roesch P, et al. Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 2007;75(11):5298-304
   PubMed Web of Science ®Google Scholar
• Haugen BJ, Pellett S, Redford P, et al. In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA. Infect Immun 2007;75(1):278-89
   PubMed Web of Science ®Google Scholar
• Anfora AT, Halladin DK, Haugen BJ, Welch RA. Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun 2008;76(12):5760-7
   PubMedGoogle Scholar
• Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135(1):41-50
   PubMed Web of Science ®Google Scholar
• Totsika M, Moriel DG, Idris A, et al. Uropathogenic Escherichia coli mediated urinary tract infection. Curr Drug Targets 2012;13(11):1386-99
   PubMedGoogle Scholar
• Amdekar S, Singh V, Singh DD. Probiotic therapy: immunomodulating approach toward urinary tract infection. Curr Microbiol 2011;63(5):484-90
   PubMedGoogle Scholar
• Song J, Abraham SN. Innate and adaptive immune responses in the urinary tract. Eur J Clin Invest 2008;38(Suppl 2):21-8
   PubMedGoogle Scholar
• Serino L, Moriel DG, Rappuoli R, Pizza M. Towards a vaccine against Escherichia coli-associated urinary tract infections. Future Microbiol 2010;5(3):351-4
   PubMedGoogle Scholar
• Lorenzo-Gomez MF, Padilla-Fernandez B, Garcia-Criado FJ, et al. Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infections versus prophylactic treatment with antibiotics. Int Urogynecol J 2013;24(1):127-34
   PubMed Web of Science ®Google Scholar
• Billips BK, Yaggie RE, Cashy JP, et al. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis 2009;200(2):263-72
   PubMed Web of Science ®Google Scholar
• Alteri CJ, Hagan EC, Sivick KE, et al. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog 2009;5(9):e1000586
   PubMed Web of Science ®Google Scholar
• Walters MS, Mobley HL. Bacterial proteomics and identification of potential vaccine targets. Expert Rev Proteomics 2010;7(2):181-4
   PubMed Web of Science ®Google Scholar
• Sivick KE, Mobley HL. An “omics” approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol 2009;17(10):431-2
   PubMedGoogle Scholar
• Cash P. Investigating pathogen biology at the level of the proteome. Proteomics 2011;11(15):3190-202
   PubMed Web of Science ®Google Scholar
• Brumbaugh AR, Mobley HL. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 2012;11(6):663-76
   PubMed Web of Science ®Google Scholar
• Bernarde C, Lehours P, Lasserre JP, et al. Complexomics study of two Helicobacter pylori strains of two pathological origins: potential targets for vaccine development and new insight in bacteria metabolism. Mol Cell Proteomics 2010;9(12):2796-826
   PubMedGoogle Scholar
• Sun X, Yang XY, Yin XF, et al. Proteomic analysis of membrane proteins from Streptococcus pneumoniae with multiple separation methods plus high accuracy mass spectrometry. OMICS 2011;15(10):683-94
   PubMedGoogle Scholar
• Choi CW, Lee YG, Kwon SO, et al. Analysis of Streptococcus pneumoniae secreted antigens by immuno-proteomic approach. Diagn Microbiol Infect Dis 2012;72(4):318-27
   PubMed Web of Science ®Google Scholar
• Roy K, Bartels S, Qadri F, Fleckenstein JM. Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun 2010;78(7):3027-35
   PubMed Web of Science ®Google Scholar
• Ashkar AA, Mossman KL, Coombes BK, et al. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog 2008;4(12):e1000233
   PubMed Web of Science ®Google Scholar
• Hannan TJ, Mysorekar IU, Hung CS, et al. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog 2010;6(8):e1001042
   PubMed Web of Science ®Google Scholar
• Klein T, Abgottspon D, Wittwer M, et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J Med Chem 2010;53(24):8627-41
   PubMed Web of Science ®Google Scholar
• Cusumano CK, Pinkner JS, Han Z, et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med 2011;3(109):109ra115
   PubMed Web of Science ®Google Scholar
• Langermann S, Palaszynski S, Barnhart M, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997;276(5312):607-11
   PubMed Web of Science ®Google Scholar
• Langermann S, Mollby R, Burlein JE, et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000;181(2):774-8
   PubMed Web of Science ®Google Scholar
• Tchesnokova V, Aprikian P, Kisiela D, et al. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli. Infect Immun 2011;79(10):3895-904
   PubMedGoogle Scholar
• Asadi Karam MR, Oloomi M, Mahdavi M, et al. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 2013;31(8):1210-16
   PubMedGoogle Scholar
• Karam MR, Oloomi M, Mahdavi M, et al. Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli. Mol Immunol 2013;54(1):32-9
   PubMedGoogle Scholar
• Durant L, Metais A, Soulama-Mouze C, et al. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli. Infect Immun 2007;75(4):1916-25
   PubMedGoogle Scholar
• Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci USA 2010;107(20):9072-7
   PubMed Web of Science ®Google Scholar
• Nesta B, Spraggon G, Alteri C, et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio 2012;3:2
   PubMedGoogle Scholar
• Wieser A, Romann E, Magistro G, et al. A multi-epitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infect Immun 2010;78(8):3432-42
   PubMed Web of Science ®Google Scholar
• Wieser A, Magistro G, Norenberg D, et al. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS). Int J Med Microbiol 2012;302(1):10-18
   PubMedGoogle Scholar
• Rai J, Lok KI, Mok CY, et al. Immunoinformatic evaluation of multiple epitope ensembles as vaccine candidates: E coli 536. Bioinformation 2012;8(6):272-5
   PubMedGoogle Scholar
• Potera C. Forging a link between biofilms and disease. Science 1999;283(5409):1837-9
   PubMed Web of Science ®Google Scholar
• Rosen DA, Hooton TM, Stamm WE, et al. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007;4(12):e329
   PubMed Web of Science ®Google Scholar
• Seneviratne CJ, Wang Y, Jin L, et al. Unraveling the resistance of microbial biofilms: has proteomics been helpful? Proteomics 2012;12(4-5):651-65
   PubMed Web of Science ®Google Scholar